NDC codes

353873 NDC codes with hospital pricing data in the network.

• NDC 61314032610_2 — FILGRASTIM-SNDZ SYRINGE (301-479 MCG) (3 hospitals, 2–20 samples)
• NDC 16729010811_2 — MITOMYCIN CHEMO SYRINGE|DISCARDED DRUG NOT ADMINISTERED (3 hospitals, 2–20 samples)
• NDC 16729010811_3 — MITOMYCIN CHEMO SYRINGE (3 hospitals, 2–20 samples)
• NDC 08888-8876-05 — KIT FOR THE PREP OF TC-99M-TILMANOCEPT SOLUTION FOR INJECTION (1-1.5 MCI) (16 hospitals, 2–20 samples)
• NDC 10122051001_2 — PORACTANT ALFA 80 MG/ML INTRATRACHEAL SUSP (MULTI GPI) (3 hospitals, 2–20 samples)
• NDC 08888-8877-77 — COPPER CU-64 DOTATATE INTRAVENOUS SOLUTION (3-4 MCI) (17 hospitals, 2–20 samples)
• NDC 08888-8878-10 — KIT FOR PREPARATION OF TC-99M-MEDRONATE SODIUM IV SOLUTION (30-60 MCI) (16 hospitals, 2–20 samples)
• NDC 00409234402_2 — DOBUTAMINE HCL 250 MG/20ML IV SOLN (3 hospitals, 2–20 samples)
• NDC 16729011505_2 — MITOMYCIN 0.2 MG/ML TOPICAL SYRINGE (OPH) (3 hospitals, 2–20 samples)
• NDC 08888-8878-55 — FLORBETABEN F-18 INTRAVENOUS SOLUTION (0-8.1 MCI) (16 hospitals, 2–20 samples)
• NDC 08888-8878-37 — IOFLUPANE I-123 INTRAVENOUS SOLUTION (16 hospitals, 2–20 samples)
• NDC 00000-0022-68 — BARICITINIB 1 MG PO TABS (1/2 TB) (1 hospital, 2–20 samples)
• NDC 70121-1637-07 — EPHEDRINE SULFATE 50 MG/ML INTRAVENOUS SOLUTION (1 hospital, 2–20 samples)
• NDC 09990827500 — NITROGLYCERIN 2 MG/10 ML (200 MCG/ML) IN 5 % DEXTROSE INTRAVENOUS (PROCEDURAL USE ONLY) (5 hospitals, 2–20 samples)
• NDC 09991287300 — MITOMYCIN INTRAOCULAR INJ 0.2 MG/0.5 ML SYR (5 hospitals, 2–20 samples)
• NDC 09991270700 — MITOMYCIN INTRAOCULAR INJ 0.2 MG/1 ML SYRINGE (5 hospitals, 2–20 samples)
• NDC 09991145700 — CEFTAZIDIME IV SYRINGE 40 MG/ML (NEO/PED) FROM STOCK SOLN (4 hospitals, 2–20 samples)
• NDC 09991146000 — CEFTAZIDIME IV SYRINGE 100 MG/ML (NEO/PED FLUID RESTRICTED) FROM STOCK SOLN (4 hospitals, 2–20 samples)
• NDC 09991345401 — MITOMYCIN 3 MG/6 ML (0.5 MG/ML) INTRAVESICAL SYRINGE (4 hospitals, 2–20 samples)
• NDC 09991315400 — CEFTAZIDIME IV SYRINGE 100 MG/ML (NEO/PED FLUID RESTRICTED) FROM STOCK SOLN (4 hospitals, 2–20 samples)
• NDC 09991262200 — MITOMYCIN INTRAOCULAR INJ 0.2 MG/0.5 ML SYR (5 hospitals, 2–20 samples)
• NDC 00078-0698-19 — MIDOSTAURIN 25 MG PO CAPS (1 hospital, 2–20 samples)
• NDC 09999903581 — CEFOXITIN (40 MG/ML) IN D5W PEDS/NICU (9 hospitals, 2–20 samples)
• NDC 09999903360 — HYDROXYZINE (25 MG/ML) IV IN D5W PEDS/NICU (9 hospitals, 2–20 samples)
• NDC 68135075620 — PEGVALIASE-PQPZ 10 MG/0.5ML SC SOSY (9 hospitals, 2–20 samples)
• NDC 68135005889 — PEGVALIASE-PQPZ 2.5 MG/0.5ML SC SOSY (9 hospitals, 2–20 samples)
• NDC 70092231744 — NEOSTIGMINE METHYLSULFATE 1 MG/ML IJ SOLN (ALL SIZES) (9 hospitals, 2–20 samples)
• NDC 09999905225 — CEFTOLOZANE-TAZOBACTAM (10-5 MG/ML) IN NS PEDS/NICU (9 hospitals, 2–20 samples)
• NDC 09999906021 — DAPTOMYCIN IV (20 MG/ML) IN NS PEDS/NICU RTA (9 hospitals, 2–20 samples)
• NDC 09917513932 — FILGRASTIM-AAFI (NIVESTYM) 15 MCG/ML (IN DEXTROSE) SIMPLE (9 hospitals, 2–20 samples)
• NDC 00338107502_2 — DOBUTAMINE 500 MG/250 ML RTU (TITRATABLE RATE/ICU) (3 hospitals, 2–20 samples)
• NDC 00002021301_2 — INSULIN REGULAR HUMAN 100 UNIT/ML FOR CORRECTIVE (3 hospitals, 2–20 samples)
• NDC 00002021301_5 — INSULIN REGULAR HUMAN 100 UNIT/ML IVP ROUTE (3 hospitals, 2–20 samples)
• NDC 66658023407_2 — ANAKINRA 100 MG/0.67ML SC SOSY (3 hospitals, 2–20 samples)
• NDC 00002850101_2 — INSULIN REGULAR HUMAN (CONC) 500 UNIT/ML SC SOLN FOR PUMP (3 hospitals, 2–20 samples)
• NDC 00002021301_3 — INSULIN REGULAR HUMAN 100 UNIT/ML FOR CORRECTIVE HIGH DOSE (3 hospitals, 2–20 samples)
• NDC 16729011505_3 — MITOMYCIN 0.3 MG/ML TOPICAL SYRINGE (OPH) (3 hospitals, 2–20 samples)
• NDC 60923051423 — DELANDISTROGENE MOXEPARVO-ROKL 23 X 10 ML IV KIT (3 hospitals, 2–20 samples)
• NDC 72511040001 — ADALIMUMAB-ATTO 40 MG/0.8ML SC SOAJ (3 hospitals, 2–20 samples)
• NDC 00002021301_4 — INSULIN REGULAR HUMAN 100 UNIT/ML FOR NEU ORDERSETS (3 hospitals, 2–20 samples)
• NDC 43598093109_2 — DESMOPRESSIN ACETATE PF 4 MCG/ML IJ SOLN (3 hospitals, 2–20 samples)
• NDC 398 — GI Cocktail suspension kit - ED formulation (1 hospital, 2–20 samples)
• NDC 57894-0100-60 — NIRAPARIB-ABIRATERONE ACETATE 100-500 MG PO TABS (1 hospital, 2–20 samples)
• NDC 57894-0240-30 — LAZERTINIB MESYLATE 240 MG PO TABS (1 hospital, 2–20 samples)
• NDC 63020-0400-02 — IXAZOMIB CITRATE 4 MG PO CAPS (1 hospital, 2–20 samples)
• NDC 64842-0120-04 — FUTIBATINIB (12 MG DAILY DOSE) 4 MG PO TBPK (1 hospital, 2–20 samples)
• NDC 00000-0002-88 — LORAZEPAM 2 MG/ML INJ SOLN (1 hospital, 2–20 samples)
• NDC 00310-0679-12 — OLAPARIB 150 MG PO TABS (1 hospital, 2–20 samples)
• NDC 00003-4040-12 — REPOTRECTINIB 40 MG PO CAPS (1 hospital, 2–20 samples)
• NDC 82154-0785-01 — RUCAPARIB CAMSYLATE 300 MG PO TABS (1 hospital, 2–20 samples)